Chakma Justin
- SEC CIK
- 0001951238
In the past year, 1 open-market sale filing worth $1.48M and no purchases.
Current role at each company
- SPRY ARS Pharmaceuticals, Inc.Chief Business Officeras of Jan 5, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.48M
- 1 filing
- Net
- −$1.48M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Chakma Justin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 14, 2025 (view filing) | Nov 12 | 2 days | Chakma JustinChief Business Officer | SSale | −166.4K | $8.87 | −$1.48M | −100.0%0 after | 2 lots |
| Dec 13, 2024 (view filing) | Dec 12-13 | 1 day | Chakma JustinChief Business Officer | SSale | −144.6K | $12.23 | −$1.77M | −51.5%136.4K after | 2 lots |
| Dec 12, 2024 (view filing) | Dec 10 | 2 days | Chakma JustinChief Business Officer | SSale | −50.0K | $13.15 | −$657.5K | −26.8%136.4K after | |
| Dec 6, 2024 (view filing) | Dec 4-6 | 2 days | Chakma JustinChief Business Officer | SSale | −144.6K | $14.11 | −$2.04M | −51.5%136.4K after | 3 lots |
| Dec 4, 2024 (view filing) | Dec 2-3 | 2 days | Chakma JustinChief Business Officer | SSale | −90.0K | $13.43 | −$1.21M | −39.8%136.4K after | 2 lots |
| Nov 27, 2024 (view filing) | Nov 25-27 | 2 days | Chakma JustinChief Business Officer | SSale | −100.0K | $14.12 | −$1.41M | −42.3%136.4K after | 3 lots |